Raising the bar in supportive care: treating nausea in cancer patients
Thank you for taking the time to fill in this survey. Your answers will help shape the innovative programme of the “Raising the bar in supportive care: treating nausea in cancer patients” symposium. Before we ask you more content-related questions, we would like to get to know you a little better.
start
 
How are you connected to the cancer supportive care community?
I am a:


 
Is your practice academic or non-academic?


 
In which setting do you work?


 
How many years are you in practice?


 
Please state your city and country of residence

 
How many cancer patients do you see, on average, per month?


 
For how many cancer patients do you prescribe a drug to prevent nausea and vomiting, on average, per month?


 
In how many patients do you observe nausea that interferes with quality of life despite your antiemetic prescription, on average, per month?


 
Here is the final set of questions. They deal with the challenges of nausea that you feel toward patient care.

How would you rate the emetic risk of carboplatin based on your personal experience in clinic?


 
Do you think we should routinely integrate patient-reported outcome measures of different side effects into daily practice?


 
Do you think we should integrate individual patient-related risk factors into the treatment recommendations in the guidelines?


 
Are you aware of, or using, an algorithm/recommendation guideline to evaluate patient risk of developing chemotherapy-induced nausea and vomiting?


 
Which one?

 
What percentage of your patients (please enter no. between 0 and 100 without %) do you estimate suffer from nausea after:

 
Initiating highly emetogenic chemotherapy (HEC)

 
Initiating anthracycline and cyclophosphamide (AC)-moderately emetogenic chemotherapy (MEC)

 
Initiating MEC

 
When “traditional” medication proves ineffective in managing patient nausea, are any of the following additional options available in your setting? (please select all that apply)

 
Pharmacological options


 
Non-pharmacological options


 
Please send us any additional comments that you have

Thank you for helping us to better understand our audience.
We are looking forward to see you at MASCC 2015 and especially at our satellite symposium: 
Raising the bar in supportive care: treating nausea in cancer patients
The Quality of Life in Oncology team.

For more information please go to 
http://qualityoflife.elsevierresource.com/save-date-annual-satellite-symposium-mascc-2015
Visit the Resource Centre